No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Analysts at Berenberg lowered their target price on Oxford Nanopore Technologies from 250p to 230p on Monday after the nanopore sequencing products developer released its full-year 2025 results.
Berenberg said Oxford Nanopore's results were "largely in line with expectations", noting that the company had delivered "a strong performance in 2025" despite a "difficult macro environment", with constant currency revenue growth ahead of guidance at 24.2%.
The German bank noted that despite "ongoing macro uncertainty", Oxford Nanopore still expects to reach EBITDA breakeven by 2027 and cash breakeven by 2028.
"However, it has adjusted the assumptions in its medium-term guidance, now expecting lower revenue growth (leading us to lower our revenue forecasts) but higher gross margins and lower operating cost growth," said Berenberg, which reiterated its 'buy' rating on the stock.
"Regardless of these changes, we continue to see substantial upside in the ONT share price."
Reporting by Iain Gilbert at Sharecast.com
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.